Placebo tablets to match S95032 drug product are supplied as white to off-white, round (10 mg) and white to off-white oblong (40 mg) film-coated tablets for oral administration., S95032/AG-881, S95032/AG-881
AG881-C-004
Phase 3 small_molecule active
Quick answer
Placebo tablets to match S95032 drug product are supplied as white to off-white, round (10 mg) and white to off-white oblong (40 mg) film-coated tablets for oral administration., S95032/AG-881, S95032/AG-881 for Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active